About this information
Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).
If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.
*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.
Download datasets of the summaries of completed access to information requests.
Current Search
Report Type
Organization
Disposition
Year
Month
Found 877 record(s)
Req # A-2022-001041
Adverse Drug Reactions (ADRs). Report numbers: E2B_05653106, E2B_05632251, E2B_05635022, E2B_05653113, E2B_05643492.Organization: Health Canada
January 2023
Req # A-2022-001084
Adverse Drug Reactions (ADRs) for ARIPIPRAZOLE. Report numbers: E2B_05628287, E2B_05628312, E2B_05628332, E2B_05646859, E2B_05657705, E2B_05664355, E2B_05665043, E2B_05665088, E2B_05704273, E2B_05712679.Organization: Health Canada
January 2023
Req # A-2022-001087
Adverse Drug Reactions (ADRs) for ABILIFY MAINTENA. Report numbers: E2B_05665045, E2B_05665144, E2B_05686891, E2B_05693250, E2B_05695992, E2B_05703028, E2B_05711493.Organization: Health Canada
January 2023
Req # A-2022-000047
Adverse Drug Reaction (ADR) for GLYCERYL TRINITRATE. Report number: E2B_05006504. ADRs for CLOPIDOGREL BISULFATE. Report numbers: E2B_04798666, E2B_04188590.Organization: Health Canada
December 2022
Req # A-2022-000809
Adverse Drug Reaction (ADR). Report number: E2B_05593974.Organization: Health Canada
December 2022
Req # A-2022-001012
Adverse Drug Reactions (ADRs) for Zenhale. Report numbers: E2B_01412713, E2B_01511788, E2B_01578394, E2B_01586148, E2B_01619809, E2B_01650004.Organization: Health Canada
December 2022
Req # A-2020-000977
All documents about the evidence that altered the government’s advice on the wearing of masks and the management of the National Emergency Strategic Stockpile that were collected to be sent to the House of Commons Health Committee before Parliament…Organization: Health Canada
December 2022
Req # A-2021-002146
The Health Canada approved package insert for Dehydrated Alcohol Injection USP (Drug Identification Number (DIN) 00394394) owned by Flon Laboratoires Inc.Organization: Health Canada
December 2022
Req # A-2022-001092
Health Canada International Affairs Team, Strategic Horizontal Policy Division, Health Products and Food Branch. the International Affairs Team, position number 00157831. How many new employees were hired under this position from the periods of 2017…Organization: Health Canada
December 2022
Req # A-2022-000716
Adverse Drug Reaction (ADR) for Entyvio. Report number: E2B_05505099.Organization: Health Canada
November 2022